HealthThe Hindu
Are lower MRPs on cancer drugs translating into affordable care? | In Focus Podcast
Read the full story at The Hindu
THGU1868388205 megaphone While the National Pharmaceutical Pricing Authority (NPPA) recent trade margin rationalisation has reduced the prices of several anti-cancer medicines, experts say India needs comprehensive cancer care, stronger price regulation, greater transparency and expanded public healthcare provision to protect patients from catastrophic expenditure. Are lower MRPs on cancer drugs translating into affordable care? Here, we discuss.
Guests: Dr. Indu Bhushan, bureaucrat, economist and the first CEO of Ayushman Bharat; Mr. K.M.
Gopakumar, legal advisor, senior researcher and public health expert. Host: Bindu Shajan Perappadan Producer: Jude Francis Weston For more episodes of In Focus:
More health
- 'Played Violent Video Games': Lawyer Of Panchkula Boy Who Attacked Girl In SchoolNDTV
- इजरायलले गाजामा बाल स्वास्थ्य र उपचार अस्वीकार गर्दछ : मानवअधिकारवादीOnlinekhabar (Nepali)
- Personal Attacks In Punjab Amid Bid To Show Who's Sober Enough To Run StateNDTV
- दैनिक एभोकाडो र आँप खाँदा मुटुको स्वास्थ्यमा उल्लेख्य सुधार: अध्ययनDC Nepal
- Why a US-funded vaccine trial on babies was cancelled in Guinea-BissauBBC
- The NHS is relying more on charities - and that might be creating problems for patientsBBC